ArticleBMC oral health2026
Algorithm-based approach to the management of rhino-maxillary mucormycosis: part II of a two-part study.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRhino-maxillary mucormycosis (RMM) is an aggressive, life-threatening fungal infection associated with substantial morbidity and mortality. While early diagnosis is universally advocated, robust quantitative evidence delineating how defined diagnostic delays influence objective clinical outcomes remains scarce. This study aimed to quantify the relationship between diagnostic timing and treatment outcomes in RMM and to develop a protocol-driven multidisciplinary algorithm to standardize management.
methodsThis retrospective case series analyzed patients diagnosed and treated for RMM at the Otolaryngology and Oral and Maxillofacial Surgery clinics of Beni-Suef University between November 2019 and December 2021. Data extraction and statistical analysis were conducted from June 2022 to January 2024. Diagnostic timing was categorized as early (4-7 days), late (8-10 days), or delayed (> 10 days). Primary outcomes included disease prognosis (regression, stabilization, progression, or death) and resolution pattern (favorable or unfavorable). Associations were evaluated using chi-square tests and Cramer's V, with statistical significance set at p < 0.05.
resultsThirty patients were included (mean age 56.53 ± 11.52 years; 60% male). Early diagnosis occurred in 40% of cases, late in 26.67%, and delayed in 33.33%. The overall survival rate was 83.33%. At final follow-up, disease regression was observed in 60% of patients, stabilization in 16.67%, and progression in 6.67%. A statistically significant association was identified between diagnostic timing and disease regression across follow-up intervals, most pronounced at the third postoperative month (χ
conclusionDiagnostic timing demonstrates a significant association with clinical outcomes in RMM. Earlier diagnosis correlates with higher rates of regression and favorable resolution patterns. Adoption of a structured diagnostic and management algorithm may facilitate early triage and coordinated multidisciplinary intervention, contributing to improved outcome standardization in oral and maxillofacial practice. Prospective validation in larger cohorts is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.